Tim, Thanks for your thoughts. I agree with you and would like to add an evaluation criteria component - these efforts (imo) should be targeted at having an impact on clinical outcome.
Joanne ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Joanne S. Luciano, PhD Rensselaer Polytechnic Institute Research Associate Professor 110 8th Street, Winslow 2143 Tetherless World Constellation Troy, NY 12180, USA Department of Computer Science Email: jluci...@cs.rpi.edu Office Tel. +1.518.276.4939 Global Tel. +1.617.440.4364 (skypeIn) On May 26, 2011, at 9:55 AM, Tim Clark wrote: > Dear HCLS colleagues > > I guess my comment would be, setting Translational Medicine as a major > priority = ok, making it the only priority = not ok. > > TM applications are important, and do potentially integrate many of the > things we have all been working on. But they are far from covering all the > bases, and far from covering all the use cases of critical concern to people > in my Task Group, Scientific Discourse. > > I'll just observe that since we launched the multiple task groups we have > ended up with two kinds of groups: > > (1) Problem Centric, e.g. TM and Scientific Discourse > (2) Solution Centric, e.g. LODD, BioRDF, Terminology > > My personal recommendation would be to formulate the charter around > accelerating biomedical research and promoting cross-discipline sharing, > across the full scientific and clinical life cycle. I would begin by > dividing into several distinct problem focused areas. I would lose the > solution-based Task Groups and reformulate them as problem-based. > > for example, BioRDF has been working on gene lists for transcriptomic > experiments, we might recharter that Task Group to work on Genomic > Experiments, for example, or whatever concept area the Task members like and > is a logical step from what they are doing now, but with a PROBLEM FOCUS ... > you see the point. > > I think each of the solution centric groups has a potential problem centric > group hiding inside it, waiting to come out. > > Best > > Tim > > On May 26, 2011, at 9:31 AM, Helena Deus wrote: > >> Hi, >> >> That is a very good point, thanks Mikel and Andrea! >> Do you have pointers to such type of data? Shall we consider an IG for >> "basic" life sciences? >> >> The LS part of HCLS has indeed been gaining adepts rapidly and it may make >> sense to reflect that in the charter. >> >> Cheers, >> Lena >> >> 2011/5/26 Mikel Egaña Aranguren <meg...@fi.upm.es> >> Hi; >> >> I should attend the conference call but I just want to add that I concur >> with Andrea in that the HCLS IG should consider the environmental realm, >> since loads of new ecological/environment data, with new challenges to be >> addressed, are waiting to be represented semantically. That's precisely one >> of the lines we are trying to open here at OEG-UPM. >> >> Cheers >> >> >> On og., 2011.eko mairen 26a 15:08, Andrea Splendiani wrote: >> Hi, >> >> I see myself as more involved in the next incarnation of the charter ;) >> Unfortunately, today is a travel day and I cannot attend the conference >> call. >> >> I have two questions/ideas, which don't really map to the current >> sub-groups, but just in case they ring some bell: >> >> -) Is the HCLS exclusively oriented on HeathCare ? (that is, is the "and" in >> Heath Care and Life Sciences IG and AND or an OR ?). Here in Rothamsted, we >> are just starting to evaluate the Ecological/Agricultural/Environmental >> connections to Life Sciences. Does this fall into the remit of the IG group >> ? >> >> -) Does the evaluation/ coordination of development of systems which link >> information representation and analysis side fall within the remit of the IG >> ? I think interfaces to linked data, as well as tools which can analyze >> linked data are important to improve the acceptance of Semantic Web >> technologies in the Life Sciences. >> >> ciao, >> Andrea >> >> >> >> >> Il giorno 24/mag/2011, alle ore 04.04, Eric Prud'hommeaux ha scritto: >> >> Hi all, as some of you reallize, the charter ends at the end of this >> month. I've been polling around to see what alternative formulations >> would give us the most resources and impact. In the process, I wrote >> up some of our high-level use cases (elevator speeches) to help us >> approach the relevant parties in pharmas, health services and >> research:<http://www.w3.org/2011/05/HCLSIGUseCases>. >> >> I'd like to discuss the landscape and potential strategies with the >> community. I'd particularly like to invite those who have been active >> or see themselves as being active in the next incarnation of the group. >> We'll discuss the current, fairly conservative draft charter >> <http://www.w3.org/2011/05/HCLSIGCharter-proposal>, as well as ways to >> optimize both its message and the paths for dissemination. An example >> of a messaging alternative would be to characterize the HCLS IG work >> in terms of e.g. overarching translational medicine use cases: >> " >> The W3C Semantic Web in Health Care and Life Sciences Interest Group >> focuses on translational medicine use cases. The group will continue >> the aggregation of cutting edge and traditional scientific knowledge >> to meet use cases for researchers, care givers, patients and >> regulatory agencies. Due to the scope and diversity of expertise >> required to meet translational needs, the HCLS IG work is broken >> down into discrete task forces focused on particular data >> acquisition, modeling and integration requirements: >> >> Terminology - identifying and integrating identifiers for biological >> processes, gross anatomy and medical procedures to promote >> unification of domain data. >> >> LODD - curation of compounds, clinical trials and outcomes. >> >> BioRDF - modeling of biological processes and actors. >> >> Scientific Discourse - representation and tracking of the changing >> landscape of scientific knowledge and the driving theora and >> experiments. >> >> Translational Medicine - the oversight and high-level ontology that >> connects these disciplines together in order to meet immediate and >> long term needs from pharma, health care and other vested parties. >> " >> . Perhaps you all have some other ideas about how to tell a story >> about our work which will serve to both draw people to our work and >> our products and to help already interested parties find the task >> forces which interest them. I of course want to draw an optimal >> balance between doing work which motivates the participants and >> focusing on tasks which will accelerate education and adoption by >> important organizations. >> >> I'm sure you are all aware of my preference for technical work, but I >> feel that this outreach can make us all ultimately more effective. I >> will use the Thursday 26 May HCLS slot (11:00 EDT) to reach out to the >> current HCLS IG community, and whomever else you folks elect to bring >> along. Of course, I'll reserve extra teleconference slots, but please >> RSVP to me privately so I can make a guess at how many ports to >> reserve. Also, please provide what feedback you can before the >> conference. Anything we take care of before will make the meeting more >> efficient. >> >> Conference Details >> >> Date of Call: Thursday, May 26, 2011 >> Time of Call: 11:00 am Eastern Time, 4 pm UK, 5 pm CET >> Dial-In #: +1.617.761.6200 (Cambridge, MA) >> [Note: limited access to European dial in numbers below] >> Dial-In #: +33.4.26.46.79.03 (Nice, France) >> Dial-In #: +44.203.318.0479 (Bristol, UK) >> Participant Access Code: 4257 ("HCLS") >> IRC Channel: irc.w3.org port 6665 channel #HCLS (see W3C IRC page for >> details, or see Web IRC), Quick Start: Use >> http://www.mibbit.com/chat/?server=irc.w3.org:6665&channel=%23hcls for >> IRC access. >> Duration: ~1 hour >> Convener: Eric Prud'hommeaux >> Scribe: TBD >> >> HCLS IG charter/strategy discussion >> -- >> -ericP >> >> Andrea Splendiani >> Senior Bioinformatics Scientist >> Centre for Mathematical and Computational Biology >> +44(0)1582 763133 ext 2004 >> andrea.splendi...@bbsrc.ac.uk >> >> >> >> >> >> >> >> -- >> Mikel Egaña Aranguren, PhD >> http://mikeleganaaranguren.com >> >> Marie Curie post-doc at Ontology Engineering Group, UPM >> http://www.oeg-upm.net/ >> >> >> >> >> >> -- >> Helena F. Deus >> Post-Doctoral Researcher at DERI/NUIG >> http://lenadeus.info/ >> > > > > The information in this e-mail is intended only for the person to whom it is > addressed. If you believe this e-mail was sent to you in error and the e-mail > contains patient information, please contact the Partners Compliance HelpLine > at > http://www.partners.org/complianceline . If the e-mail was sent to you in > error > but does not contain patient information, please contact the sender and > properly > dispose of the e-mail. ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
